ROSENBLUM MARK J (Exec VP Finance, Interim CFO) purchased 5K shares of DECOY THERAPEUTICS INC. on the open market
Open‑market purchase worth $4.3K. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 2/13/2020ACC: 0001615219-20-000001
Officer· Exec VP Finance, Interim CFO
Since Sep 2019
+5K
Net shares
Net buyer
$4.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
5K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5K
Price / share
$0.86
Trade value
$4.29K
% of position
New position
2/13/2020
0.00→5K
Total
Net shares
+5K
Net value
$4.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/13/2020 | P · Purchase | +5K | $0.86 | $4.29K | New position | 0.00 | 5K |
| Total | +5K | $4.29K | ||||||
Derivative Transactions0
No derivative transactions reported